Pyramid Pharma 6 Ltd
13467517
Some Concerns
- Current liabilities exceed current assets (-10)
- 3 outstanding charges (-6)
Details
Compliance
Last accounts
30/09/2025
total exemption full
Next accounts due
30/06/2027
Confirmation statement
Last: 06/06/2026
Due 20/06/2027
Industry
Officers
director · Since 30/06/2022
DIRECTOR
BRITISH · ENGLAND · Age 38
Also on 7 other boards
director · Since 03/09/2025
DIRECTOR
BRITISH · UNITED KINGDOM · Age 35
Also on 1 other board
Former
director · Resigned 30/06/2022
Persons with Significant Control
Rey London Limited
59, Chislehurst Road, Chislehurst, BR7 5NP
Reg: 08688397 · Uk · Company
Notified 30/06/2022
Former PSCs
Pyramid Pharma Pharmaceuticals Limited
Ceased 30/06/2022
Charges3 outstanding
LLOYDS BANK PLC
LLOYDS BANK PLC
LLOYDS BANK PLC
Change History
Active
Private Limited Company
59 HIGH STREET
CHISLEHURST
CompanyRankvs 1227+ SIC 47730 peers62
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Outstanding charges: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 30/09/2025
Net Worth
£808k
Balance sheet strength
Cash
£334k
Cash in the bank
Net Current Assets
£1.2M
Working capital
Current Assets
£1.7M
Current Liabilities
£520k
Fixed Assets
£124k
Debtors
£1.3M
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | 3.25 | +£425k |
| 2024 | 3.43 | +£304k |
| 2023 | 1.31 | — |
Derived from filed accounts. Not audited figures.